Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer
Clinical trial NCT06667960 · RECRUITING
Trial details
- NCT number
- NCT06667960
- Sponsor
- Salubris Biotherapeutics Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-23
- Primary completion
- 2028-04-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.